CME Group Inc., through its various subsidiaries, manages international marketplaces for the exchange of futures and options on futures contracts worldwide. Its extensive array of product offerings includes futures and options linked to a broad spectrum of underlying assets, such as interest rates, equity indices, fore…
An institutional-grade, numbers-driven thesis on CME — generated on demand from live fundamentals, scores and forecast.
Member feature · 7-day free trial · no charge today · cancel anytime
As of August 8, 2026, TradersQuant's model rates CME Group Inc. (CME) 61/100 with a 12-month base-case forecast of $304.80 — +15.6% versus the current price of $263.66. CME Group Inc. trades at $263.66 in the Financial Services sector, with a market capitalisation of $94.81B. The score blends valuation, growth, earnings quality and momentum into a single grade.
The 12-month analyst consensus price target for CME is $304.80, implying +15.6% versus the current price. The model's 12-month scenario range runs from $289.06 (bear) to $338.21 (bull), with a base case of $304.33.
On the fundamentals, CME Group shows a P/E of 22.2, trailing revenue of $6.52B, revenue growth of +6.4% YoY, a dividend yield of 4.27%. This page also tracks CME's short interest, institutional (smart-money) positioning and the options market — the same cross-signal view institutions watch.
CME currently carries a TradersQuant composite score of 61/100, which we read as a neutral-to-watch signal. The Wall-Street analyst consensus is "Hold". Our 12-month price target of $304.80 implies +15.6% from $263.66. This is research, not financial advice — always combine it with your own judgement.
The analyst consensus price target for CME is $304.80, about +15.6% versus the latest price of $263.66. Consensus is based on 37 analysts.
TradersQuant's 12-month model forecast for CME is a base case of $304.33, ranging from $289.06 (bear) to $338.21 (bull), an expected return of +15.4%. Forecasts are model estimates, not guarantees.
The TradersQuant price prediction for CME over the next 12 months is $304.33 in the base case (bear $289.06, bull $338.21), versus today's price of $263.66. Unlike black-box prediction sites, every TradersQuant call is logged at the price and date it was made and graded publicly against the S&P 500.
We deliberately don't publish 2030 price predictions for CME — no model can honestly forecast a single stock five-plus years out, and sites that do are guessing. TradersQuant focuses on a rigorous 12-month bull/base/bear range, refreshed continuously and graded on our public track record.
TradersQuant estimates CME's fair value at $304.80, implying +15.6% of expected upside versus the current price.
Yes — CME Group pays a dividend yielding 4.27% (about $11.25 per share annually).
Data and model outputs are for research only and are not financial advice. Figures update continuously.
